Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Chemocentryx Inc
(NQ:
CCXI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 19, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Chemocentryx Inc
< Previous
1
2
3
4
5
6
Next >
Recap: ChemoCentryx Q4 Earnings
March 01, 2022
ChemoCentryx (NASDAQ:CCXI) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine...
Via
Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...
Via
Benzinga
Earnings Preview: ChemoCentryx
February 28, 2022
ChemoCentryx (NASDAQ:CCXI) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first...
Via
Benzinga
Is Now The Time To Buy Stock In ChemoCentryx, Ideanomics Or Snowflake?
February 25, 2022
Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings b...
Via
Benzinga
Why ChemoCentryx Shares Are Rising
January 19, 2022
ChemoCentryx Inc (NASDAQ:CCXI) shares are trading higher a...
Via
Benzinga
ChemoCentryx's Avacopan Scores European Approval For ANCA-Associated Vasculitis
January 19, 2022
The European Union has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) for ANCA-associated vasculitis. The approval follows the FDA approval of...
Via
Benzinga
Expert Ratings For ChemoCentryx
November 10, 2021
Analysts have provided the following ratings for ChemoCentryx (NASDAQ:CCXI...
Via
Benzinga
ChemoCentryx, inc (CCXI) Q3 2021 Earnings Call Transcript
November 10, 2021
CCXI earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a...
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
Is It Too Late to Buy ChemoCentryx Stock?
October 14, 2021
The stock surged after obtaining FDA approval for avacopan.
Via
The Motley Fool
Exposures
Product Safety
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
2 Super-Charged Growth Stocks to Buy Now
October 13, 2021
These two small drugmakers are poised for a long-winded growth spurt.
Via
The Motley Fool
45 Biggest Movers From Yesterday
October 13, 2021
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on...
Via
Benzinga
BZ Chart Of The Day: ChemoCentryx
October 11, 2021
There’s an old saying on Wall Street that "gaps refill." It's true and it may be about to happen to shares of ChemoCent...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021
October 11, 2021
Upgrades According to Vertical Research, the prior rating for C.H. Robinson Worldwide Inc (NASDAQ:
Via
Benzinga
Thinking About Buying Stock In Starbucks, Peloton Or ChemoCentryx?
October 11, 2021
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It Moving, or WIIM, feature in...
Via
Benzinga
Futures Slide As Soaring Oil Nears $85
October 11, 2021
While cash bonds may be closed, one can easily extrapolate where they would be trading based on TSY futures which are currently trading at a 1.65% equivalent.
Via
Talk Markets
Topics
Bonds
Exposures
Debt Markets
10 Biggest Price Target Changes For Monday
October 11, 2021
Keybanc lifted Netflix, Inc. (NASDAQ: NFLX) price target from $645 to $670. Netflix shares rose 0.1% to $633.00 in pre-market trading. JMP Securities raised ServiceNow, Inc. (...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Down; Crude Oil Jumps 2%
October 11, 2021
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Nasdaq dropped around 75 points in the previous session. Futures for the Dow Jones Industrial...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
35 Biggest Movers From Friday
October 11, 2021
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for...
Via
Benzinga
Exposures
Product Safety
5 Stocks To Watch For October 11, 2021
October 11, 2021
Some of the stocks that may grab investor focus today are: Mandiant Inc (NASDAQ: MNDT) reported the completion of divestiture of its FireEye Products unit to McAfee Enterprise...
Via
Benzinga
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
October 10, 2021
Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive stocks and into risky bets...
Via
Talk Markets
Exposures
Product Safety
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
October 10, 2021
Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive...
Via
Benzinga
Exposures
Product Safety
Why ChemoCentryx Stock Skyrocketed Today
October 08, 2021
Investors are excited about the biotech's game-changing new drug.
Via
The Motley Fool
Mid-Afternoon Market Update: Dow Surges 80 Points; ChemoCentryx Shares Spike Higher
October 08, 2021
Toward the end of trading Friday, the Dow traded up 0.24% to 34,835.06 while the NASDAQ fell 0.13% to 14,635.04. The S&P also rose, gaining 0.13% to 4,405.69. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ChemoCentryx, Allogene Show the Risks and Rewards of Nasdaq Biotech Stocks
October 08, 2021
The broader market was mixed on Friday.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
October 08, 2021
Gainers ChemoCentryx (NASDAQ:CCXI) stock increased by 70.43% to $33.41 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 74.6...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.